Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Oral Medicine · Oral Leukoplakia

Why Is Tongue or Floor-of-Mouth Leukoplakia High Risk?

At a Glance

Oral leukoplakia on the side or underside of the tongue or on the floor of the mouth has a higher statistical chance of becoming oral cancer, but location alone cannot predict an individual outcome. Biopsy findings, appearance, size, and tobacco or alcohol exposure also shape risk.

When a persistent white patch in the mouth that cannot be explained by another condition (oral leukoplakia) is found on the side or underside of the tongue (ventrolateral border) or the floor of the mouth, clinicians consider it to be at a higher risk for malignant transformation (turning into oral cancer).

It is crucial to understand what this “high risk” designation means. It does not mean the patch is already cancer, nor is it a guarantee that it will become cancer. Instead, it is a population-level statistical association observed over decades of research [1]. For your doctor, a leukoplakia in these locations acts as a warning sign that the area requires a thorough professional assessment, typically a tissue biopsy, and careful monitoring.

What the Clinical Data Shows

Medical research consistently highlights the increased risk associated with the tongue and floor of the mouth, though the exact numbers vary between studies depending on how patients were selected and followed.

  • Increased Odds: Large reviews of multiple studies have shown that leukoplakias on the tongue or floor of the mouth are roughly two to four times more likely to transform into cancer than lesions at other oral sites like the cheeks or gums [2][1].
  • Lateral Tongue Estimates: One meta-analysis estimated that, across the studied populations, about 12.7% of leukoplakias on the lateral (side) tongue eventually transformed into cancer [3].

These statistics represent averages across large groups of people, not your individual personal risk. Your specific risk depends heavily on the cellular makeup of the patch, its appearance, your habits, and your medical history [4].

Proposed Reasons for the Higher Risk

While the clinical risk is a proven association [1][5], the exact biological reasons why these specific areas are more vulnerable are still being studied. Researchers have proposed several theories:

  • Saliva Pooling and Exposures: Gravity causes saliva to naturally pool in the floor of the mouth. If a person uses tobacco or drinks alcohol, the cancer-causing chemicals (carcinogens) dissolve in this saliva. It is hypothesized that this prolonged contact may increase the risk of cellular damage in these specific tissues [6].
  • Thinner Tissue Barrier: The mucosal lining (epithelium) on the floor of the mouth and the underside of the tongue is thinner and less protected by keratin (a tough protein) than the tissue on the gums or the roof of the mouth. This might make it easier for harmful substances to penetrate and affect the underlying cells [7].
  • Field Cancerization: This is the concept that long-term exposure to damaging factors (like tobacco) can cause genetic changes across a broad area of the mouth, even in tissue that looks completely normal [8]. When cancer does develop in patients with leukoplakia, it sometimes appears in entirely new spots in the mouth, rather than directly from the original white patch [9]. The floor of the mouth and side of the tongue may simply be areas where this widespread tissue change is most likely to show up first.

Location Is Only One Piece of the Puzzle

Location is never used in isolation to predict risk. The physical appearance of the spot and what the cells look like under a microscope are critical pieces of information:

  • Epithelial Dysplasia: The most important risk factor is whether a biopsy shows dysplasia (a spectrum of abnormal, pre-cancerous cell changes). In one large study, lesions with severe dysplasia had an estimated 5-year risk of turning into cancer of up to 32.2% [10]. While severe dysplasia is a strong warning sign, it is not cancer.
  • Lesion Appearance: Leukoplakia that is nonhomogeneous (meaning it is speckled with red, bumpy, thick, or ulcerated) carries a significantly higher risk than a flat, uniform white patch [3][2].
  • Lesion Size: Larger patches, especially those over 200 mm² (roughly the size of a nickel or 2 square centimeters), are associated with a greater chance of transformation [3][2].

A biopsy showing no dysplasia is highly reassuring and lowers immediate concern. However, because leukoplakia can change over time, and because a biopsy sample might miss a tiny area of abnormal cells, long-term monitoring is still recommended even with a reassuring initial result [10][11][12].

Diagnosis, Treatment, and Monitoring

Because you cannot determine the risk of a lesion simply by looking at it, relying on appearance or location alone is not enough.

The Role of Biopsy
Histopathology—examining tissue under a microscope—is the standard way to assess dysplasia [12][13]. Your clinician will likely recommend a biopsy. Depending on the size of the lesion, this may be an incisional biopsy (removing a small piece) or an excisional biopsy (removing the whole patch). Because a large or irregular lesion can have different cells in different areas, persistent or changing spots may require repeat biopsies [12][13].

Considerations for Surgical Removal
The location of the leukoplakia alone does not dictate that it must be surgically removed. The decision to remove a lesion depends on the grade of dysplasia, its size, whether complete removal is practical, and the potential impact on your speech and swallowing. Furthermore, surgical removal or laser treatment does not eliminate the risk of “field cancerization,” meaning new lesions could still develop nearby in the future [9].

Reducing Your Risk Factors
While leukoplakia is not always caused by lifestyle factors, you can take active steps to protect your oral health. If you use tobacco (smoked or smokeless) or areca/betel nut products, stopping is highly recommended. Reducing or avoiding alcohol, especially in combination with tobacco, can also lower your overall risk [3]. Your doctor can provide non-judgmental support and resources for cessation.

Individualized Surveillance and Warning Signs
Most patients with oral leukoplakia in high-risk sites will need long-term surveillance. There is no single schedule for everyone; your follow-up intervals will be customized based on your biopsy results, lesion appearance, and risk factors [14]. At these visits, your doctor should examine your entire mouth and neck, not just the original patch [9].

When to Call Your Doctor Sooner
Do not wait for your next scheduled appointment if you notice any of the following changes in your mouth:

  • Rapid growth of the white patch
  • The appearance of a new red area within or near the patch
  • A persistent ulcer or sore that bleeds or does not heal
  • Increasing pain, firmness, or a new lump
  • Numbness or difficulty moving your tongue, swallowing, or speaking

Common questions in this guide

Does a high-risk location mean my leukoplakia is already cancer?
No. A high-risk location means that, in groups of patients, leukoplakia there has been more likely to become oral cancer than leukoplakia at some other sites. It does not prove that your patch is cancer or that it will become cancer; a tissue biopsy and follow-up are needed to assess your individual risk.
Why are leukoplakias on the tongue or floor of the mouth considered higher risk?
Research links these locations with a higher chance of a patch turning into oral cancer, although the exact biological reasons are still being studied. Saliva can pool in the floor of the mouth, and the lining there and under the tongue is thinner and less protected; tobacco and alcohol exposures may add to tissue damage.
What can a biopsy tell me about my oral leukoplakia?
A biopsy examines cells under a microscope for dysplasia, meaning abnormal changes that can precede cancer. The degree of dysplasia is one of the most important factors in estimating risk. A result with no dysplasia is reassuring, but follow-up is still recommended because changes can develop later or a small abnormal area may not have been sampled.
Does a high-risk location mean the leukoplakia must be removed?
Not necessarily. Doctors consider dysplasia, size, appearance, whether the whole patch can be removed, and possible effects on speech and swallowing. Surgery or laser treatment may remove the visible patch but cannot prevent new patches elsewhere in a mouth affected by long-term tissue changes.
Can I lower my risk if I have oral leukoplakia?
Stopping tobacco and areca or betel nut products is strongly recommended, and reducing or avoiding alcohol is especially important if you use tobacco. A doctor can offer nonjudgmental cessation support. These steps protect oral health but do not replace biopsy or surveillance.
Which changes in a leukoplakia need prompt medical attention?
Contact your clinician sooner if the patch grows quickly, develops a red area, forms a sore that does not heal or bleeds, becomes painful or firm, or is associated with a lump, numbness, or difficulty moving your tongue, swallowing, or speaking. These changes do not prove cancer, but they require prompt professional assessment.
How frequently should high-risk oral leukoplakia be monitored?
There is no single follow-up schedule for everyone. Your clinician should base visit timing on the biopsy findings, lesion appearance, size, and risk factors, and follow-up should include the entire mouth and neck rather than only the original patch.

Get notified when new evidence is published on oral mucosa leukoplakia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study.

    Evren I, Brouns ER, Wils LJ, et al.

    Oral oncology 2020; (110()):105014 doi:10.1016/j.oraloncology.2020.105014.

    PMID: 33038723
  2. 2

    Clinical predictors of malignant transformation and recurrence in oral potentially malignant disorders: A systematic review and meta-analysis.

    Paglioni MP, Khurram SA, Ruiz BII, et al.

    Oral surgery, oral medicine, oral pathology and oral radiology 2022; (134(5)):573-587 doi:10.1016/j.oooo.2022.07.006.

    PMID: 36153299
  3. 3

    Malignant transformation of oral leukoplakia: Systematic review and comprehensive meta-analysis.

    Pimenta-Barros LA, Ramos-García P, González-Moles MÁ, et al.

    Oral diseases 2025; (31(1)):69-80 doi:10.1111/odi.15140.

    PMID: 39314164
  4. 4

    Malignant transformation rate of oral leukoplakia in the past 20 years: A systematic review and meta-analysis.

    Guan JY, Luo YH, Lin YY, et al.

    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2023; (52(8)):691-700 doi:10.1111/jop.13440.

    PMID: 37224426
  5. 5

    Clinicopathologic factors associated with malignant transformation of oral leukoplakias: a retrospective cohort study.

    Jäwert F, Pettersson H, Jagefeldt E, et al.

    International journal of oral and maxillofacial surgery 2021; (50(11)):1422-1428 doi:10.1016/j.ijom.2021.01.012.

    PMID: 33674140
  6. 6

    Malignant transformation of oral leukoplakia treated with carbon dioxide laser: a meta-analysis.

    Dong Y, Chen Y, Tao Y, et al.

    Lasers in medical science 2019; (34(1)):209-221 doi:10.1007/s10103-018-2674-7.

    PMID: 30443884
  7. 7

    Optical Coherence Tomography (OCT) Evaluation of Thermal Tissue Alterations After Diode Laser Excision of Oral Leukoplakia (OL).

    Gambino A, Magliano A, Haddad GE, et al.

    Dentistry journal 2026; (14(3)) doi:10.3390/dj14030168.

    PMID: 41892776
  8. 8

    Oral leukoplakia-to treat or not to treat.

    Holmstrup P, Dabelsteen E

    Oral diseases 2016; (22(6)):494-7 doi:10.1111/odi.12443.

    PMID: 26785709
  9. 9

    Profiling cancer risk in oral potentially malignant disorders-A patient cohort study.

    Thomson PJ, Goodson ML, Smith DR

    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2017; (46(10)):888-895 doi:10.1111/jop.12625.

    PMID: 28833670
  10. 10

    Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study.

    Chaturvedi AK, Udaltsova N, Engels EA, et al.

    Journal of the National Cancer Institute 2020; (112(10)):1047-1054 doi:10.1093/jnci/djz238.

    PMID: 31860085
  11. 11

    Oral precursor lesions and malignant transformation--who, where, what, and when?

    Goodson ML, Sloan P, Robinson CM, et al.

    The British journal of oral & maxillofacial surgery 2015; (53(9)):831-5.

    PMID: 26388071
  12. 12

    Clinical features and presentation of oral potentially malignant disorders.

    Warnakulasuriya S

    Oral surgery, oral medicine, oral pathology and oral radiology 2018; (125(6)):582-590 doi:10.1016/j.oooo.2018.03.011.

    PMID: 29673799
  13. 13

    When Clinical Suspicion Outweighs a Negative Biopsy: Early Tongue Squamous Cell Carcinoma Diagnosed After Persistent Oral Leukoplakia.

    Reboredo P, Nogueira P, Boer N, et al.

    Cureus 2026; (18(8)):e114040 doi:10.7759/cureus.114040.

    PMID: 42701507
  14. 14

    Malignant Transformation in Oral Potentially Malignant Disorders.

    González-Moles MÁ, Ramos-García P, Warnakulasuriya S

    Oral diseases 2026; doi:10.1111/odi.70527.

    PMID: 42830481

This page is for informational purposes only and does not constitute medical advice. Your dentist, oral specialist, or doctor should interpret your biopsy and recommend follow-up for your specific situation.